CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CYTR's Operating Income Growth by Quarter and Year

Cytrx's Operating Income results by quarter and year




CYTR Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 1.20 -5.64 -9.97
III Quarter September -1.55 -3.02 -8.17 -11.70
II Quarter June -1.53 -2.51 -9.30 -18.48
I Quarter March -1.74 -3.92 -9.75 -12.11
FY   -4.82 -8.25 -32.86 -52.26



CYTR Operating Income third quarter 2019 Y/Y Growth Comment
Cytrx Corp in the third quarter recorded Operating Loss of $ -1.55 millions.

According to the results reported in the third quarter, Cytrx Corp achieved the best Operating Income growth in Biotechnology & Drugs industry. While Cytrx Corp' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


CYTR Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cytrx's third quarter 2019 Operating Income $ -1.55 millions CYTR's Income Statement
Cytrx's third quarter 2018 Operating Income $ -3.02 millions Quarterly CYTR's Income Statement
New: More CYTR's historic Operating Income Growth >>


CYTR Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Cytrx's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYTR's III. Quarter Q/Q Operating Income Comment
III. Quarter 2019 accomplishment of -1.55 millions by Cytrx Corp come out even less good if you take a look at Operating Loss -1.53 millions in the second quarter.

Within Biotechnology & Drugs industry Cytrx Corp achieved highest sequential Operating Income growth. While Cytrx's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYTR's III. Quarter Q/Q Operating Income Comment
III. Quarter 2019 Operating Loss of -1.55 millions by Cytrx Corp appear even more unfavourable if you take a look at -1.53 millions Operating Loss in the previous quarter.

Within Biotechnology & Drugs industry Cytrx Corp achieved highest sequential Operating Income growth. While Cytrx's Operating Income growth quarter on quarter, overall rank is .


Cytrx's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -3.62 $ -5.09 $ -6.07 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Cytrx Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Cytrx Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CYTR's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CYTR's Competitors
Operating Income Growth for Cytrx's Suppliers
Operating Income Growth for CYTR's Customers

You may also want to know
CYTR's Annual Growth Rates CYTR's Profitability Ratios CYTR's Asset Turnover Ratio CYTR's Dividend Growth
CYTR's Roe CYTR's Valuation Ratios CYTR's Financial Strength Ratios CYTR's Dividend Payout Ratio
CYTR's Roa CYTR's Inventory Turnover Ratio CYTR's Growth Rates CYTR's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2019
Utah Medical Products Inc -0.70 %$ -0.704 millions
Laboratory Corp Of America Holdings -1.02 %$ -1.019 millions
Prestige Consumer Healthcare Inc. -2.22 %$ -2.222 millions
Atrion Corp -2.85 %$ -2.854 millions
Merck & Co., Inc. -4.45 %$ -4.452 millions
Procyon Corp -5.41 %$ -5.412 millions
Amphastar Pharmaceuticals, Inc. -5.73 %$ -5.725 millions
Exelixis, Inc. -7.65 %$ -7.645 millions
Zynex Inc -11.52 %$ -11.525 millions
Encision Inc -12.87 %$ -12.872 millions
Biotelemetry, Inc. -13.68 %$ -13.680 millions
Pro Dex Inc -13.72 %$ -13.715 millions
Hill-rom Holdings, Inc. -16.58 %$ -16.578 millions
Healthcare Services Group Inc -25.73 %$ -25.731 millions
Universal Health Services Inc -26.53 %$ -26.534 millions
Ani Pharmaceuticals Inc -27.55 %$ -27.546 millions
Magellan Health, inc. -27.58 %$ -27.576 millions
Jazz Pharmaceuticals Plc -29.49 %$ -29.492 millions
Jrsis Health Care Corp -32.14 %$ -32.136 millions
Petmed Express Inc -36.60 %$ -36.598 millions
Psychemedics Corp -37.08 %$ -37.075 millions
Techcare Corp. -39.68 %$ -39.680 millions
Synergy Chc Corp. -43.21 %$ -43.213 millions
Alpha Pro Tech Ltd -48.78 %$ -48.785 millions
Vertex Pharmaceuticals Inc -51.70 %$ -51.698 millions
Phibro Animal Health Corp -55.60 %$ -55.599 millions
Diffusion Pharmaceuticals Inc. -56.23 %$ -56.226 millions
Pdl Biopharma, Inc. -74.30 %$ -74.298 millions
Apollo Medical Holdings, Inc. -82.21 %$ -82.208 millions
Mallinckrodt Plc -85.18 %$ -85.179 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

POAI's Profile

Stock Price

POAI's Financials

Business Description

Fundamentals

Charts & Quotes

POAI's News

Suppliers

POAI's Competitors

Customers & Markets

Economic Indicators

POAI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071